NCT02539199View on ClinicalTrials.gov

Vaginally Administered Versus Per Oral Misoprostol in Induction of Labour

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 2, 2018

Study Completion Date

March 2, 2018

Conditions
Labour Induction
Interventions
DRUG

Misoprostol, modified-release pessary

Misoprostol pessary (7 ug/h) placed in vaginal fornix until labour is induced or maximum 24 hours

DRUG

Misoprostol, per-oral tablets

First day: 50 ug PO in every 4 hours maximum 3 times per day. Second day: 100 ug PO in every 4 hours maximum 3 times per day. Third day: 50 ug vaginally in every 4 hours maximum 3 times per day or until labour is induced.

Trial Locations (5)

Unknown

Helsinki University hospital, Helsinki

Kuopio University Hospital, Kuopio

Oulu University Hospital, Oulu

Tampere University Hospital, Tampere

Turku University Hospital, Turku

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

collaborator

Oulu University Hospital

OTHER

lead

Tampere University Hospital

OTHER

NCT02539199 - Vaginally Administered Versus Per Oral Misoprostol in Induction of Labour | Biotech Hunter | Biotech Hunter